Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Study of seasonality of attacks in MOG antibody-associated disease.
Francis A, Santos M, Leal Rato M, Wintle YM, Brex P, Chen B, Cooper S, Dobson R, Geraldes R, Hemingway C, Huda S, Messina S, Ramdas S, Leite MI, Palace J. Francis A, et al. Among authors: brex p. Mult Scler Relat Disord. 2024 Oct;90:105814. doi: 10.1016/j.msard.2024.105814. Epub 2024 Aug 10. Mult Scler Relat Disord. 2024. PMID: 39151237
Prescribing in pregnancy: navigating risks and benefits.
Dobson R, Ovadia C, Mathews J, Brex P. Dobson R, et al. Among authors: brex p. Pract Neurol. 2023 Oct;23(5):366-367. doi: 10.1136/pn-2023-003812. Epub 2023 Jul 24. Pract Neurol. 2023. PMID: 37487704 No abstract available.
Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus.
Iyer P, Wiles K, Ismail A, Nanda S, Murray K, Hughes S, Ford HL, Pearson OR, White S, Bonham N, Hoyle N, Witts J, Middleton R, Brex PA, Rog D, Dobson R. Iyer P, et al. Among authors: brex pa. Mult Scler. 2023 Mar;29(3):395-406. doi: 10.1177/13524585221148094. Epub 2023 Feb 5. Mult Scler. 2023. PMID: 36740816
Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing Scheme.
Giovannoni G, Brex PA, Dhiraj D, Fullarton J, Freddi M, Rodgers-Gray B, Schmierer K. Giovannoni G, et al. Among authors: brex pa. Mult Scler J Exp Transl Clin. 2019 Dec 5;5(4):2055217319893103. doi: 10.1177/2055217319893103. eCollection 2019 Oct-Dec. Mult Scler J Exp Transl Clin. 2019. PMID: 31839981 Free PMC article.
47 results